Fortrea (FTRE) to Release Quarterly Earnings on Tuesday

Fortrea (NASDAQ:FTRE) is scheduled to release its earnings data before the market opens on Tuesday, May 7th. Analysts expect Fortrea to post earnings of ($0.01) per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Fortrea (NASDAQ:FTRE) last announced its earnings results on Monday, March 11th. The company reported $0.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.04). The firm had revenue of $775.40 million during the quarter, compared to the consensus estimate of $779.09 million. The company’s revenue for the quarter was up 1.8% compared to the same quarter last year. On average, analysts expect Fortrea to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Fortrea Trading Up 3.3 %

NASDAQ:FTRE opened at $37.54 on Tuesday. The stock has a fifty day simple moving average of $37.96 and a 200 day simple moving average of $33.76. Fortrea has a 1-year low of $24.92 and a 1-year high of $41.02. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.90.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on FTRE. Robert W. Baird assumed coverage on shares of Fortrea in a research report on Friday, March 22nd. They issued a “neutral” rating and a $43.00 target price on the stock. Jefferies Financial Group initiated coverage on shares of Fortrea in a research report on Thursday, January 4th. They set a “buy” rating and a $44.00 price objective on the stock. Barclays reduced their target price on Fortrea from $38.00 to $35.00 and set an “overweight” rating for the company in a report on Thursday, January 25th. Deutsche Bank Aktiengesellschaft started coverage on Fortrea in a report on Wednesday, March 6th. They set a “hold” rating and a $36.00 price target on the stock. Finally, William Blair started coverage on Fortrea in a research note on Friday, January 5th. They issued a “market perform” rating for the company. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Fortrea has an average rating of “Hold” and an average target price of $37.29.

Fortrea Company Profile

Fortrea Holdings Inc, a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum.